Warning letter
Dorneyville Pharmacy: warning letter of Feb 7, 2017
FDA warning letter 510866 · Philadelphia District Office
Key facts
| Reference number | 510866 |
|---|---|
| Company | Dorneyville Pharmacy |
| Subject | Compounding Pharmacy/Adulterated Drug Products |
| Issue date | Feb 7, 2017 |
| Posted date | Mar 21, 2017 |
| Issuing office | Philadelphia District Office |
| Product type | Drugs |
| CFR sections cited | 211.167(a), 211.67(a), 211.94(c), 211.113(b), 201.115, 211.28(a), 211.42(c)(10)(iv) |
| Inspection city | Allentown |
| Inspection ZIP | 18103 |
| Inspection start date | Dec 9, 2015 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: